Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 228

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 4
Chunk 228
---
 or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

39

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

    60 DEGREES PHARMACEUTICALS, INC.

    Dated: May 15, 2025
    /s/ Geoffrey Dow

    Geoffrey Dow

    Chief Executive Officer and President, Director
    (Principal Executive Officer)

    Dated: May 15, 2025
    /s/ Tyrone Miller

    Tyrone Miller

    Chief Financial Officer
    (Principal Financial and Accounting Officer)

40

WA

0001946563
false
Q1
--12-31

    0001946563

    2025-01-01
    2025-03-31

    0001946563
    
      sxtp:CommonStockParValue00001PerShareMember

    2025-01-01
    2025-03-31

    0001946563
    
      sxtp:WarrantsEachWarrantToPurchaseOneShareOfCommonStockMember

    2025-01-01
    2025-03-31

    0001946563

    2025-05-15

    0001946563

    2025-03-31

    0001946563

    2024-12-31

    0001946563
    
      us-gaap:SeriesAPreferredStockMember

    2025-03-31

    0001946563
    
      us-gaap:SeriesAPreferredStockMember

    2024-12-31

    0001946563

    2024-01-01
    2024-03-31

    0001946563
    
      us-gaap:SeriesAPreferredStockMember
      us-gaap:PreferredStockMember

    2024-12-31

    0001946563
    
      us-gaap:CommonStockMember

    2024-12-